NCT05160584: A Study of Real-Life Current Standards of Care in Participants With RRMM (MoMMent)
Updated: Feb 10
NCT05160584: A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma (MoMMent)
NCT05160584: A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma (MoMMent)
The purpose of this study is to assess in real-life clinical practice, over a 24-month period, the effectiveness and safety of current standard of care (SOC) antimyeloma treatments in participants with previously treated relapsed and/or refractory multiple myeloma.
Sponsor
ClinicalTrials.gov Identifier: NCT05160584
Official Title: A Prospective, Multinational Study of Real-Life Current Standards of Care in Patients With Relapsed and/or Refractory Multiple Myeloma
First Posted : December 16, 2021
Click here for details on ClinicalTrials.gov
Locations
Locations
Europe
Belgium
France
Germany
Netherlands
Italy
Spain
United Kingdom